Thus, these findings indicate that the lack of cathepsin K in patients with pycnodysostosis impacts not only bone remodeling but also bone quality, which probably cannot be attributed solely to disrupted osteoclast activity. The gene discussed is CTSK; the disease is pycnodysostosis.